Skip to main content
Fig. 5 | BMC Complementary Medicine and Therapies

Fig. 5

From: Antiviral activity of silymarin in comparison with baicalein against EV-A71

Fig. 5

Silymarin and baicalein exhibited antiviral activities against EV-A71 in combined virucidal and cell protection assays in a dose-dependent manner. Inhibition of viral infectivity by silymarin determined by 5(a) plaque assays and 5(b) quantification of RNA copy number. Inhibition of viral infectivity by baicalein determined by 5(c) plaque assays and 5(d) quantification of RNA copy. Data presented as mean ± S.E.M. Error bars indicate the range of values obtained from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 indicates a significant difference compared to the negative control (0 μg/mL) analysed by t-test

Back to article page